--- title: "U.S. stock night trading opens with fluctuations: Moderna plummets 7.64% in night trading without significant negative news, as capital speculation intensifies volatility" type: "News" locale: "en" url: "https://longbridge.com/en/news/296414471.md" description: "Moderna fell 7.64% in after-hours trading; Lion Group Holding rose 20.77% in after-hours trading; Evaxion A/S rose 19.68% in after-hours trading; Webull rose 12.85% in after-hours trading" datetime: "2026-08-20T00:27:49.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296414471.md) - [en](https://longbridge.com/en/news/296414471.md) - [zh-HK](https://longbridge.com/zh-HK/news/296414471.md) generator: "portal-rs" --- # U.S. stock night trading opens with fluctuations: Moderna plummets 7.64% in night trading without significant negative news, as capital speculation intensifies volatility **U.S. Stock Night Market Opening Movements** Moderna fell 7.64% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. **Top Gainers in the U.S. Night Market** Lion Group Holding rose 20.77% in the night market. Based on recent key news: 1. On August 18, Lion Group Holding released an important announcement through the EDGAR system regarding the company's financial status and future development plans. This announcement attracted market attention, driving the stock price up by 20.77%. Source: EDGAR 2. Recent changes in the macroeconomic environment have led companies to adjust their strategies to meet challenges. Lion Group Holding's positioning in the decentralized finance sector is viewed by the market as a proactive measure, enhancing investor confidence. Source: PUBT 3. Changes in infrastructure trends within the industry have prompted the company to optimize its debt structure and improve operational efficiency. The strategic adjustments of Lion Group Holding are considered important measures to adapt to the current economic environment, further driving the stock price up. Source: PUBT Macroeconomic changes impact the financial industry. Evaxion A/S rose 19.68% in the night market. Based on recent key news: 1. On August 17, Evaxion A/S announced the expansion of its cancer vaccine program, launching the EVX-05 vaccine targeting glioblastoma. This news boosted market confidence, driving the stock price up. 2. On August 17, the company confirmed that the costs related to EVX-05 have been included in the existing budget, with no impact on cash flow, expected to sustain until the second half of 2027. This financial robustness further enhanced investor confidence. 3. On August 17, Evaxion A/S announced a conference call on August 20 to present business updates and financial results for the second quarter of 2026, which the market is eagerly anticipating, propelling the stock price upward. The biotechnology industry has been active recently, with significant capital inflows. WeBull rose 12.85% in the night market. Based on recent key news: 1. On August 20, WeBull announced record second-quarter results, with revenue increasing by 51% year-on-year and adjusted operating profit rising by 169%. Trading volume and customer assets reached historical highs, with strong international and institutional expansion, and AI tools being widely adopted. These factors drove the stock price up. Source: 24/7 Wall St. 2. On August 19, WeBull announced its second-quarter financial report, exceeding market expectations. The adjusted net profit was $43.2 million, with a net profit margin of 21.7%. Strong trading-related revenue and interest income growth were the main drivers. Source: Zhitong Finance 3. On August 19, analysts rated WeBull as "Moderate Buy," predicting a price target of $13, indicating a 39% upside from the current price. Source: Refinitiv News Support The fintech industry is performing strongly, with significant capital inflows ### Related Stocks - [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md) - [LGHL.US](https://longbridge.com/en/quote/LGHL.US.md) - [EVAX.US](https://longbridge.com/en/quote/EVAX.US.md) - [BULL.US](https://longbridge.com/en/quote/BULL.US.md) ## Related News & Research - [Moderna stock soars on cancer vaccine success](https://longbridge.com/en/news/296405393.md) - [MEXC Lists Ondo Tokenized Stock Moderna (MRNAON), Expanding Access to U.S. Biotech Exposure](https://longbridge.com/en/news/296603043.md) - [If You Invested $1,000 In Moderna Stock at IPO, Here's How Much You'd Have Now](https://longbridge.com/en/news/296641626.md) - [Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.](https://longbridge.com/en/news/296643850.md) - [Moderna’s 177% Surge Has Investors Asking What Comes Next](https://longbridge.com/en/news/296610623.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**